in an open uncontrolled trial , we treated 57 patients suffering from psoriasis ( 32 ) and various severe skin disorders ( 25 ) with daily doses ranging from 20 to 150 micrograms , during 1 to 130 weeks ( mean = 12 weeks ) .
C0033860
psoriasis
C0037274
skin disorders